isocoumarins has been researched along with Kahler Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agata, N; Kharbanda, S; Kufe, D; Milhollen, M; Nogi, H | 1 |
| Agata, N; Avigan, D; Kawano, T; Kharbanda, S; Kufe, D | 1 |
2 other study(ies) available for isocoumarins and Kahler Disease
| Article | Year |
|---|---|
2-(8-Hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl)propionic acid, a small molecule isocoumarin, potentiates dexamethasone-induced apoptosis of human multiple myeloma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Carrier Proteins; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor; Coumarins; Cytochromes c; Dexamethasone; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Humans; Intracellular Signaling Peptides and Proteins; Isocoumarins; Mitochondria; Mitochondrial Proteins; Multiple Myeloma; Reactive Oxygen Species | 2004 |
A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells.
Topics: Antimitotic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Isocoumarins; Microtubules; Mitosis; Multiple Myeloma | 2007 |